Humira and Synjardy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humira (adalimumab) and Synjardy (empagliflozin; metformin hydrochloride). Common drug interactions include postoperative wound infection among females and nerve compression among males.

The phase IV clinical study analyzes what interactions people have when they take Humira and Synjardy. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,396 Humira users. Check the latest studies of Humira.

What is Synjardy?

Synjardy has active ingredients of empagliflozin; metformin hydrochloride. eHealthMe is studying from 2,928 Synjardy users. Check the latest studies of Synjardy.



On Jul, 14, 2026

32 people who take Humira and Synjardy together, and have interactions are studied.

Humira and Synjardy drug interactions.

What are the common drug interactions of Humira and Synjardy, by gender? *:

female:

  1. Postoperative wound infection
  2. Rash
  3. Rectal haemorrhage (bleeding from anus)
  4. Surgery
  5. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  6. Thyroidectomy
  7. Vertigo
  8. Vomiting
  9. Pain
  10. Alopecia (absence of hair from areas of the body)

male:

  1. Nerve compression
  2. Mobility decreased (ability to move is reduced)
  3. Pain in jaw
  4. Peripheral swelling
  5. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  6. Spinal disorder (disease of spine a back bone)
  7. Trismus (reduced opening of the jaws)
  8. Weight increased
  9. Drug ineffective
  10. Dysstasia (difficulty in standing)

What are the common drug interactions of Humira and Synjardy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Injection site papule (solid pimple or swelling at injection site)

40-49:

  1. Aortic dilatation
  2. Diarrhoea
  3. Headache (pain in head)
  4. Nausea (feeling of having an urge to vomit)
  5. Photophobia (extreme sensitivity to light)
  6. Vision blurred

50-59:

  1. Blood thyroid stimulating hormone increased
  2. Hypersensitivity
  3. Pneumonia
  4. Rhinorrhoea (watery mucus discharge from the nose)
  5. Thyroid mass
  6. Alopecia (absence of hair from areas of the body)
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Blood iron decreased
  9. Cold sweat
  10. Dizziness

60+:

  1. Blood glucose increased
  2. Abdominal distension
  3. Peripheral swelling
  4. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  5. Spinal disorder (disease of spine a back bone)
  6. Trismus (reduced opening of the jaws)
  7. Weight increased
  8. Cataract (clouding of the lens inside the eye)
  9. Arthralgia (joint pain)
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Diabetes: 12 people, 37.50%
  2. High Blood Cholesterol: 9 people, 28.12%
  3. High Blood Pressure: 6 people, 18.75%
  4. Type 2 Diabetes: 5 people, 15.62%
  5. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 15.62%
  6. Depression: 5 people, 15.62%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 12.50%
  8. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 9.38%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.38%
  10. Pain: 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Humira and Synjardy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Humira and Synjardy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Humira:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Synjardy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humira and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Synjardy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on adalimumab and empagliflozin; metformin hydrochloride (the active ingredients of Humira and Synjardy, respectively), and Humira and Synjardy (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: